These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7864095)

  • 41. Participation of transient-type Ca2+ channels in the sustained increase of Ca2+ level in GH3 cells.
    Suzuki N; Kudo Y; Takagi H; Yoshioka T; Tanakadate A; Kano M
    J Cell Physiol; 1990 Jul; 144(1):62-8. PubMed ID: 2164034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone-releasing factor-sensitive adenylate cyclase system of purified somatotrophs: effects of guanine nucleotides, somatostatin, calcium, and magnesium.
    Narayanan N; Lussier B; French M; Moor B; Kraicer J
    Endocrinology; 1989 Jan; 124(1):484-95. PubMed ID: 2562826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathways.
    Han XF; Zhu YL; Hernandez M; Keating DJ; Chen C
    Endocrine; 2005 Nov; 28(2):217-24. PubMed ID: 16388096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-adrenergic modulation of ionic currents in cultured parasympathetic neurons from rat intracardiac ganglia.
    Xu ZJ; Adams DJ
    J Neurophysiol; 1993 Apr; 69(4):1060-70. PubMed ID: 8098358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries.
    Goodyer CG; Branchaud CL; Lefebvre Y
    J Clin Endocrinol Metab; 1993 May; 76(5):1259-64. PubMed ID: 8098715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth hormone-releasing factor-44 specificity for components of somatotroph and lactotroph immediate release pool substructures.
    Stachura ME; Tyler JM
    Endocrinology; 1987 May; 120(5):1719-26. PubMed ID: 3032568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells.
    Lledo PM; Legendre P; Israel JM; Vincent JD
    Endocrinology; 1990 Sep; 127(3):990-1001. PubMed ID: 2167220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor.
    de Zegher F; Daaboul J; Grumbach MM; Kaplan SL
    Endocrinology; 1989 Mar; 124(3):1114-7. PubMed ID: 2563681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dependence of the excitability of pituitary cells on cyclic nucleotides.
    Stojilkovic SS; Kretschmannova K; Tomić M; Stratakis CA
    J Neuroendocrinol; 2012 Sep; 24(9):1183-200. PubMed ID: 22564128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms of pituitary endocrine cell calcium handling.
    Stojilkovic SS
    Cell Calcium; 2012; 51(3-4):212-21. PubMed ID: 22138111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression and role of hyperpolarization-activated and cyclic nucleotide-gated channels in endocrine anterior pituitary cells.
    Kretschmannova K; Kucka M; Gonzalez-Iglesias AE; Stojilkovic SS
    Mol Endocrinol; 2012 Jan; 26(1):153-64. PubMed ID: 22135067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of nonselective cation channels in spontaneous and protein kinase A-stimulated calcium signaling in pituitary cells.
    Tomić M; Kucka M; Kretschmannova K; Li S; Nesterova M; Stratakis CA; Stojilkovic SS
    Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E370-9. PubMed ID: 21586701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ion channels and signaling in the pituitary gland.
    Stojilkovic SS; Tabak J; Bertram R
    Endocr Rev; 2010 Dec; 31(6):845-915. PubMed ID: 20650859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.
    Kim E; Sohn S; Lee M; Park C; Jung J; Park S
    Pituitary; 2005; 8(2):155-62. PubMed ID: 16379030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The in vitro regulation of growth hormone secretion by orexins.
    Chen C; Xu R
    Endocrine; 2003 Oct; 22(1):57-66. PubMed ID: 14610299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human GHRH reduces voltage-gated K+ currents via a non-cAMP-dependent but PKC-mediated pathway in human GH adenoma cells.
    Xu R; Roh SG; Loneragan K; Pullar M; Chen C
    J Physiol; 1999 Nov; 520 Pt 3(Pt 3):697-707. PubMed ID: 10545137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.
    Chen C; Farnworth P; Petersenn S; Musgrave I; Canny BJ; Clarke IJ
    Endocrine; 1998 Aug; 9(1):71-7. PubMed ID: 9798733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone-releasing hormone triggers pacemaker activity and persistent Ca2+ oscillations in rat somatotrophs.
    Kwiecien R; Tseeb V; Kurchikov A; Kordon C; Hammond C
    J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):613-23. PubMed ID: 9130158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. G(o)-2 protein mediates the reduction in Ca2+ currents by somatostatin in cultured ovine somatotrophs.
    Chen C; Clarke IJ
    J Physiol; 1996 Feb; 491 ( Pt 1)(Pt 1):21-9. PubMed ID: 9011613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of Ca2+ influx in the ovine somatotroph by growth hormone-releasing factor.
    Chen C; Clarke IJ
    Am J Physiol; 1995 Feb; 268(2 Pt 1):E204-12. PubMed ID: 7864095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.